3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Prostatic Neoplasms
8
Colonic Neoplasms
7
Neoplasms
5
Colorectal Neoplasms
5
Multiple Myeloma
4
Smoldering Multiple Myeloma
3
Monoclonal Gammopathy of Undetermined Significance
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Radiodermatitis
2
Pancreatic Neoplasms
2
Pain
2
Esophageal Neoplasms
2
Breast Carcinoma In Situ
2
Adenomatous Polyposis Coli
2
cyclopia sequence
1
Uterine Neoplasms
1
Tuberous Sclerosis
1
Thrombocythemia, Essential
1
Stomatitis
1
Sezary Syndrome
1
Seizures
1
Psychological Well-Being
1
Prostate Cancer Metastatic Castration Resistant
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Levetiracetam
6
perampanel
2
Tranexamic Acid
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vigabatrin
1
Vecuronium Bromide
1
Vancomycin
1
Tobramycin
1
Standard of Care
1
Spironolactone
1
Sodium Chloride
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Remifentanil
1
Propofol
1
Pregabalin
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Magnesium Sulfate
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Seizures
×
Curcumin
×
Clear all
NCT03254680
2018-04-30
Turmeric as Treatment in Epilepsy
NYU Langone Health
Phase NA
Withdrawn